| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.76e-08 | 11 | 168 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.48e-08 | 14 | 168 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.07e-07 | 37 | 168 | 6 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.25e-07 | 21 | 168 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.30e-06 | 46 | 168 | 6 | GO:0016893 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.39e-05 | 37 | 168 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.59e-05 | 38 | 168 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.59e-05 | 38 | 168 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.43e-05 | 79 | 168 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | metallodipeptidase activity | 6.72e-05 | 10 | 168 | 3 | GO:0070573 | |
| GeneOntologyMolecularFunction | dynactin binding | 1.22e-04 | 12 | 168 | 3 | GO:0034452 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | BICD2 LIMA1 NRAP LIN7C ANK2 ANK3 SPTBN1 MYRIP EML2 CLASP2 ITPRID2 ANKRD23 CLIP1 SPTBN5 PTPN3 MTUS1 ANKRD2 PAFAH1B1 MACF1 CEP295 LIMCH1 NOS2 | 1.40e-04 | 1099 | 168 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TCEA2 DPEP1 MYRIP ZNF407 CHD3 ERVK-7 ERVK-10 CLIP1 MEP1A CRYZ ERVK-8 SF3A3 UBR3 LTA4H MME HERC2 ERVK-11 TRIM44 | 1.87e-04 | 891 | 168 | 19 | GO:0008270 |
| GeneOntologyMolecularFunction | L27 domain binding | 4.18e-04 | 4 | 168 | 2 | GO:0097016 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 TCEA2 DPEP1 MYRIP ZNF407 CHD3 ERVK-7 ERVK-10 HRNR PPEF1 CLIP1 MEP1A CRYZ AOC3 ERVK-8 SF3A3 UBR3 LTA4H MME HERC2 ERVK-11 TRIM44 | 4.20e-04 | 1189 | 168 | 22 | GO:0046914 |
| GeneOntologyMolecularFunction | dipeptidase activity | 4.35e-04 | 18 | 168 | 3 | GO:0016805 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 8.01e-04 | 22 | 168 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.04e-03 | 136 | 168 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.04e-03 | 136 | 168 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.04e-03 | 24 | 168 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 DPEP1 MASP1 ERVK-7 ERVK-10 MEP1A YOD1 USP2 ERVK-8 ERVK-18 LTA4H ADAM17 MME VCPIP1 | 1.30e-03 | 654 | 168 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 TRPM2 PPP2R3B HRNR PPEF1 TBC1D9 HMCN1 AOC3 PCDH11X PCDH15 MACF1 CDH3 AGRN RCN3 PROS1 | 1.69e-03 | 749 | 168 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.73e-03 | 262 | 168 | 8 | GO:0140097 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.25e-08 | 13 | 169 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | BICD2 LIMA1 GPR65 ARHGEF5 SPTBN1 TRPM2 NUBP1 EML2 CLASP2 ANKRD23 CLIP1 SPTBN5 AKAP9 KANK3 PAFAH1B1 CEP295 LIMCH1 AGRN ARAP1 | 3.01e-07 | 579 | 169 | 19 | GO:0051493 |
| GeneOntologyBiologicalProcess | actin filament-based process | AKAP6 LIMA1 NRAP GPR65 ANK2 ARHGEF5 SPTBN1 TRPM2 MYRIP CLASP2 SIRPB1 ANKRD23 BCAR1 SPTBN5 AKAP9 HMCN1 KANK3 PAFAH1B1 PCDH15 MYOM2 LIMCH1 ARAP1 | 5.70e-06 | 912 | 169 | 22 | GO:0030029 |
| GeneOntologyBiologicalProcess | centrosome localization | 9.26e-06 | 35 | 169 | 5 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.07e-05 | 36 | 169 | 5 | GO:0061842 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | AKAP6 LIMA1 GPR65 ANK2 ARHGEF5 SPTBN1 TRPM2 CLASP2 ANKRD23 SPTBN5 AKAP9 KANK3 LIMCH1 ARAP1 | 1.58e-05 | 438 | 169 | 14 | GO:0032970 |
| GeneOntologyBiologicalProcess | endomembrane system organization | TOR1AIP2 DNAJC13 ATP8B4 ANK2 ANK3 SPTBN1 GOLGA8R RTN3 CLASP2 SPTBN5 GOLGA8DP AKAP9 GOLGA8CP FER1L4 PAFAH1B1 AGRN VCPIP1 | 3.93e-05 | 672 | 169 | 17 | GO:0010256 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 4.48e-05 | 48 | 169 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 6.65e-05 | 122 | 169 | 7 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | LIMA1 GPR65 ARHGEF5 SPTBN1 EML2 CLASP2 ANKRD23 CLIP1 SPTBN5 AKAP9 KANK3 LIMCH1 ARAP1 | 6.85e-05 | 438 | 169 | 13 | GO:1902903 |
| GeneOntologyBiologicalProcess | Golgi organization | 7.53e-05 | 168 | 169 | 8 | GO:0007030 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | LIMA1 NRAP GPR65 ARHGEF5 SPTBN1 TRPM2 CLASP2 SIRPB1 ANKRD23 BCAR1 SPTBN5 HMCN1 KANK3 PAFAH1B1 PCDH15 MYOM2 LIMCH1 ARAP1 | 1.09e-04 | 803 | 169 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | LIMA1 EPPK1 NRAP GPR65 ARHGEF5 SPTBN1 EML2 CLASP2 SIRPB1 ANKRD23 BCAR1 CLIP1 SPTBN5 AKAP9 KANK3 PAFAH1B1 PCDH15 MYOM2 LIMCH1 ARAP1 | 1.16e-04 | 957 | 169 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | BICD2 NUBP1 EML2 CLASP2 CLIP1 AKAP9 PAFAH1B1 MACF1 CEP295 AGRN | 1.57e-04 | 293 | 169 | 10 | GO:0032886 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.62e-04 | 239 | 169 | 9 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transporter activity | 1.67e-04 | 63 | 169 | 5 | GO:1901016 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | RAPGEF6 LIN7C ANK2 ANK3 SPTBN1 NUBP1 CLASP2 CLIP1 WDR59 LIN7A MACF1 HECTD1 | 1.95e-04 | 422 | 169 | 12 | GO:1990778 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 2.04e-04 | 194 | 169 | 8 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 2.53e-04 | 107 | 169 | 6 | GO:0051492 | |
| GeneOntologyBiologicalProcess | actin filament organization | LIMA1 NRAP GPR65 ARHGEF5 SPTBN1 CLASP2 SIRPB1 BCAR1 SPTBN5 KANK3 PCDH15 LIMCH1 ARAP1 | 3.00e-04 | 509 | 169 | 13 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | LIMA1 GPR65 ARHGEF5 SPTBN1 TRPM2 CLASP2 ANKRD23 SPTBN5 KANK3 LIMCH1 ARAP1 | 3.38e-04 | 384 | 169 | 11 | GO:0032956 |
| GeneOntologyCellularComponent | intercalated disc | 2.25e-04 | 68 | 169 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | ruffle | 2.80e-04 | 206 | 169 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 ARHGAP32 LIN7C ANK2 ANK3 SPTBN1 PSD3 RTN3 LIN7A AKAP9 PTPRZ1 MACF1 | 3.16e-04 | 451 | 169 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 ARHGAP32 LIN7C ANK2 ANK3 SPTBN1 PENK PSD3 RTN3 LIN7A AKAP9 PTPRZ1 MACF1 | 3.42e-04 | 523 | 169 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 ARHGAP32 LIN7C ANK2 ANK3 SPTBN1 PSD3 RTN3 LIN7A AKAP9 PTPRZ1 MACF1 | 5.21e-04 | 477 | 169 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | MPP7-DLG1-LIN7 complex | 6.39e-04 | 5 | 169 | 2 | GO:0097025 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 ARHGAP32 LIN7C ANK2 ANK3 SPTBN1 PSD3 RTN3 LIN7A AKAP9 PTPRZ1 MACF1 | 8.29e-04 | 503 | 169 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | cell cortex | ARHGAP32 SPTBN1 MYRIP CLASP2 CLIP1 SPTBN5 HMCN1 PAFAH1B1 MACF1 NOS2 | 9.05e-04 | 371 | 169 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | muscle tendon junction | 9.54e-04 | 6 | 169 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.00e-03 | 94 | 169 | 5 | GO:0044291 | |
| Domain | Ank | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 1.40e-09 | 228 | 162 | 15 | PF00023 |
| Domain | - | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 4.43e-09 | 248 | 162 | 15 | 1.25.40.20 |
| Domain | ANK | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 5.21e-09 | 251 | 162 | 15 | SM00248 |
| Domain | Ank_2 | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A HECTD1 ANKS3 | 5.79e-09 | 215 | 162 | 14 | PF12796 |
| Domain | ANK_REPEAT | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 5.81e-09 | 253 | 162 | 15 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 6.13e-09 | 254 | 162 | 15 | IPR020683 |
| Domain | ANK_REP_REGION | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 6.13e-09 | 254 | 162 | 15 | PS50297 |
| Domain | Ankyrin_rpt | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A CAMTA1 HECTD1 ANKS3 | 9.31e-09 | 262 | 162 | 15 | IPR002110 |
| Domain | PH_dom-spectrin-type | 5.18e-05 | 9 | 162 | 3 | IPR001605 | |
| Domain | SPEC | 1.62e-04 | 32 | 162 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.62e-04 | 32 | 162 | 4 | IPR018159 | |
| Domain | - | 2.17e-04 | 14 | 162 | 3 | 2.60.40.1180 | |
| Domain | CHD_N | 2.23e-04 | 3 | 162 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.23e-04 | 3 | 162 | 2 | IPR012957 | |
| Domain | CHDCT2 | 2.23e-04 | 3 | 162 | 2 | PF08074 | |
| Domain | CHDNT | 2.23e-04 | 3 | 162 | 2 | PF08073 | |
| Domain | DUF1086 | 2.23e-04 | 3 | 162 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.23e-04 | 3 | 162 | 2 | IPR009463 | |
| Domain | DUF1087 | 2.23e-04 | 3 | 162 | 2 | PF06465 | |
| Domain | DUF1086 | 2.23e-04 | 3 | 162 | 2 | PF06461 | |
| Domain | DUF1087 | 2.23e-04 | 3 | 162 | 2 | SM01147 | |
| Domain | DUF1086 | 2.23e-04 | 3 | 162 | 2 | SM01146 | |
| Domain | Glyco_hydro_b | 2.70e-04 | 15 | 162 | 3 | IPR013780 | |
| Domain | FOXP-CC | 4.44e-04 | 4 | 162 | 2 | PF16159 | |
| Domain | FOXP-CC | 4.44e-04 | 4 | 162 | 2 | IPR032354 | |
| Domain | Mib_Herc2 | 4.44e-04 | 4 | 162 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 4.44e-04 | 4 | 162 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 4.44e-04 | 4 | 162 | 2 | PF06701 | |
| Domain | Glyco_hydro_38_C | 7.35e-04 | 5 | 162 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 7.35e-04 | 5 | 162 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 7.35e-04 | 5 | 162 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 7.35e-04 | 5 | 162 | 2 | PF01074 | |
| Domain | - | 7.35e-04 | 5 | 162 | 2 | 1.20.1270.50 | |
| Domain | - | 7.35e-04 | 5 | 162 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 7.35e-04 | 5 | 162 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 7.35e-04 | 5 | 162 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 7.35e-04 | 5 | 162 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 7.35e-04 | 5 | 162 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 7.35e-04 | 5 | 162 | 2 | PF07748 | |
| Domain | VWFA | 7.35e-04 | 82 | 162 | 5 | PS50234 | |
| Domain | VWA | 8.21e-04 | 84 | 162 | 5 | SM00327 | |
| Domain | Spectrin | 9.99e-04 | 23 | 162 | 3 | PF00435 | |
| Domain | ACTININ_2 | 9.99e-04 | 23 | 162 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.99e-04 | 23 | 162 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 9.99e-04 | 23 | 162 | 3 | IPR001589 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 3.90.1290.10 | |
| Domain | PDZ | 1.45e-03 | 141 | 162 | 6 | PF00595 | |
| Domain | Plectin | 1.53e-03 | 7 | 162 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.53e-03 | 7 | 162 | 2 | IPR001101 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 1.53e-03 | 7 | 162 | 2 | IPR011330 | |
| Domain | PLEC | 1.53e-03 | 7 | 162 | 2 | SM00250 | |
| Domain | VWF_A | 1.71e-03 | 99 | 162 | 5 | IPR002035 | |
| Domain | PDZ | 1.86e-03 | 148 | 162 | 6 | SM00228 | |
| Domain | Spectrin_repeat | 1.98e-03 | 29 | 162 | 3 | IPR002017 | |
| Domain | - | 1.99e-03 | 150 | 162 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.06e-03 | 151 | 162 | 6 | PS50106 | |
| Domain | PDZ | 2.13e-03 | 152 | 162 | 6 | IPR001478 | |
| Domain | CH | 2.45e-03 | 65 | 162 | 4 | SM00033 | |
| Pubmed | TOR1AIP2 ARHGAP32 ZNF609 DNAJC13 ACOT8 AGO2 ANK3 SPTBN1 PSD3 PPP2R3B CLASP2 ITPRID2 BCAR1 SLC39A10 PPEF1 C2CD4C GMPS PTPN3 AKAP9 MTUS1 PTPRZ1 UBR3 PDZD8 HERC2 | 4.80e-10 | 1049 | 172 | 24 | 27880917 | |
| Pubmed | AKAP6 SLC12A6 MAN2A2 NRAP ANK2 DOCK9 SPTBN1 ZNF407 CLASP2 ANKRD23 CLIP1 JMJD1C AKAP9 AOC3 MACF1 MYOM2 LONRF3 | 5.40e-10 | 497 | 172 | 17 | 23414517 | |
| Pubmed | AKAP6 TOR1AIP2 RAPGEF6 ANK3 DOCK9 SPTBN1 CLASP2 CHD3 RBM28 SLC39A10 ANKRD6 WDFY4 F13A1 MTHFD1 INTS13 ZBTB10 MACF1 LMAN2 BOD1L1 CEP295 ADAM17 DOT1L CAMTA1 AGRN | 9.20e-10 | 1084 | 172 | 24 | 11544199 | |
| Pubmed | TANC2 TOR1AIP2 ZNF609 ACOT8 AGO2 FOXP2 VPS50 CHD3 SIRPB1 RALGAPA2 CCNT1 FOXP4 THADA MTUS1 INTS13 ANKRD2 CHD5 BRD7 ZBTB10 MACF1 CEP295 ADAM17 LONRF3 ANKS3 | 1.63e-09 | 1116 | 172 | 24 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ARHGAP32 LIMA1 RAPGEF6 ARHGEF5 SPTBN1 PSD3 CLASP2 ITPRID2 BCAR1 WDR59 PIK3R4 PTPN3 AKAP9 MTUS1 MACF1 BOD1L1 LIMCH1 HECTD1 VCPIP1 | 1.17e-08 | 861 | 172 | 20 | 36931259 |
| Pubmed | 1.65e-08 | 128 | 172 | 9 | 30995482 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 ZNF609 DNAJC13 AGO2 MAN2B2 ANK3 SOBP TRPM2 MYRIP RTN3 CLASP2 CHD3 BCAR1 PCGF3 JMJD1C GMPS FOXP4 THADA GUCY1A1 MACF1 BOD1L1 LIMCH1 MME CAMTA1 HECTD1 ARAP1 | 2.33e-08 | 1489 | 172 | 26 | 28611215 |
| Pubmed | TANC2 ARHGAP32 ATP8B4 MAN2B2 ZNF407 ANKRD6 RALGAPA2 WDFY4 JMJD1C WDR59 TBC1D9 THADA UBR3 MACF1 HECTD1 | 2.76e-08 | 493 | 172 | 15 | 15368895 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 ANKS6 RAPGEF6 EPPK1 MAN2A2 DOCK9 EML2 CLASP2 RALGAPA2 WDR59 TBC1D9 THADA ZNF335 CHD5 KANK3 PDZD8 HERC2 DOT1L HECTD1 AGRN ARAP1 | 1.49e-07 | 1105 | 172 | 21 | 35748872 |
| Pubmed | TANC2 ARHGAP32 LIMA1 DNAJC13 AGO2 ANK2 ANK3 FOXP2 SPTBN1 CLASP2 SIRPB1 CLIP1 AKAP9 SRGAP3 BRD7 MACF1 LIMCH1 HERC2 AGRN | 3.47e-07 | 963 | 172 | 19 | 28671696 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 22851317 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.74e-07 | 4 | 172 | 3 | 10469592 | |
| Pubmed | 9.25e-07 | 151 | 172 | 8 | 17043677 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.07e-06 | 37 | 172 | 5 | 27565344 | |
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 1.18e-06 | 5 | 172 | 3 | 17113391 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.18e-06 | 5 | 172 | 3 | 12629516 | |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 11104771 | ||
| Pubmed | TOR1AIP2 SLC12A6 DNAJC13 ANKS6 SLC26A2 RTN3 SLC39A10 WDR59 PIK3R4 SLC7A2 OSBPL1A PDZD8 ADAM17 | 1.53e-06 | 504 | 172 | 13 | 34432599 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 ZNF609 RAPGEF6 EPPK1 ANK3 ARHGEF5 ITPRID2 HRNR BCAR1 CHD5 CAMTA1 ARAP1 | 1.75e-06 | 430 | 172 | 12 | 35044719 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.38e-06 | 120 | 172 | 7 | 31413325 | |
| Pubmed | TANC2 SLC12A6 ARHGAP32 LIMA1 DNAJC13 AGO2 ANK2 ANK3 SPTBN1 PSD3 RTN3 CLASP2 CHD3 OMG PIK3R4 MTHFD1 PTPRZ1 SRGAP3 PAFAH1B1 MACF1 LIMCH1 CPNE4 | 2.54e-06 | 1431 | 172 | 22 | 37142655 | |
| Pubmed | 4.10e-06 | 7 | 172 | 3 | 9753324 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TOR1AIP2 ZNF609 ACOT8 MAN2B2 PUSL1 RDH13 RBM28 SLC39A10 WDR59 IBTK AKAP9 LMAN2 LIMCH1 HERC2 HECTD1 | 5.74e-06 | 754 | 172 | 15 | 33060197 |
| Pubmed | BICD2 DOCK9 PSD3 SLC39A10 AKAP9 SRGAP3 MACF1 BOD1L1 LIMCH1 CAMTA1 VCPIP1 | 6.45e-06 | 407 | 172 | 11 | 12693553 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 PTBP3 DNAJC13 EPPK1 SPTBN1 CHD3 GMPS PIK3R4 INTS13 BRD7 SF3A3 MACF1 ARAP1 | 7.29e-06 | 582 | 172 | 13 | 20467437 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.61e-06 | 94 | 172 | 6 | 21542922 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BICD2 LIMA1 DNAJC13 RAPGEF6 GCFC2 SPTBN1 CHD3 ZNF224 ITPRID2 CLIP1 TBC1D9 CHTF18 ZNF335 LIMCH1 VCPIP1 | 7.84e-06 | 774 | 172 | 15 | 15302935 |
| Pubmed | LIMA1 EPPK1 SPTBN1 PPP2R3B ITPRID2 HRNR CLIP1 THADA AKAP9 MTHFD1 LTA4H LMAN2 | 8.60e-06 | 503 | 172 | 12 | 36217030 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.39e-05 | 10 | 172 | 3 | 22159418 | |
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 1.39e-05 | 10 | 172 | 3 | 18854161 | |
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 14960569 | ||
| Pubmed | 1.46e-05 | 288 | 172 | 9 | 38496616 | ||
| Pubmed | BICD2 TANC2 ARHGAP32 ANK2 ANK3 DOCK9 SPTBN1 APBA1 PSD3 RTN3 LIN7A GMPS MTHFD1 SRGAP3 UBR3 MACF1 CPNE4 VCPIP1 | 1.54e-05 | 1139 | 172 | 18 | 36417873 | |
| Pubmed | 1.76e-05 | 225 | 172 | 8 | 12168954 | ||
| Pubmed | ZNF609 GCFC2 VPS50 CLASP2 RBM28 JMJD1C WDR59 IBTK SF3A3 PDZD8 BOD1L1 CEP295 HECTD1 VCPIP1 | 1.87e-05 | 733 | 172 | 14 | 34672954 | |
| Pubmed | AKAP6 BICD2 ZNF234 ANK2 ANK3 SPTBN1 APBA1 MYRIP ZNF224 ANKRD6 WDR59 PIK3R4 USP2 OSBPL1A PDZD8 MACF1 HERC2 HECTD1 VCPIP1 | 2.21e-05 | 1285 | 172 | 19 | 35914814 | |
| Pubmed | No association of FOXP2 and PTPRZ1 on 7q31 with autism from the Japanese population. | 2.43e-05 | 2 | 172 | 2 | 15998549 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11960710 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31209033 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26327442 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9425289 | ||
| Pubmed | Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes. | 2.43e-05 | 2 | 172 | 2 | 15262991 | |
| Pubmed | Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3. | 2.43e-05 | 2 | 172 | 2 | 24998259 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12207026 | ||
| Pubmed | Association of TGIFLX/Y mRNA expression with prostate cancer. | 2.43e-05 | 2 | 172 | 2 | 18663611 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17074766 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12226713 | ||
| Pubmed | Association of TGIFLX/Y mRNA expression with azoospermia in infertile men. | 2.43e-05 | 2 | 172 | 2 | 18384077 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34502327 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11940666 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 2.43e-05 | 2 | 172 | 2 | 25383926 | |
| Pubmed | Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia. | 2.43e-05 | 2 | 172 | 2 | 25632041 | |
| Pubmed | A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. | 2.43e-05 | 2 | 172 | 2 | 17855633 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.43e-05 | 2 | 172 | 2 | 11672541 | |
| Pubmed | Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. | 2.53e-05 | 12 | 172 | 3 | 10846156 | |
| Pubmed | ARHGAP32 ANK2 ANK3 SPTBN1 PSD3 JMJD1C GMPS MTHFD1 PDZD8 MACF1 LMAN2 BOD1L1 VCPIP1 | 5.58e-05 | 708 | 172 | 13 | 39231216 | |
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 6.35e-05 | 16 | 172 | 3 | 21745462 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.81e-05 | 351 | 172 | 9 | 38297188 | |
| Pubmed | Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle. | 7.27e-05 | 3 | 172 | 2 | 17392382 | |
| Pubmed | A three-gene expression signature model for risk stratification of patients with neuroblastoma. | 7.27e-05 | 3 | 172 | 2 | 22328561 | |
| Pubmed | Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. | 7.27e-05 | 3 | 172 | 2 | 17620337 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 14516685 | ||
| Pubmed | Protein phosphatase 2A interacts with the Src kinase substrate p130(CAS). | 7.27e-05 | 3 | 172 | 2 | 11593413 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 25589673 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 7.27e-05 | 3 | 172 | 2 | 19907493 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 15611082 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 24736439 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 9971820 | ||
| Pubmed | Human Asunder promotes dynein recruitment and centrosomal tethering to the nucleus at mitotic entry. | 7.27e-05 | 3 | 172 | 2 | 23097494 | |
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 7.27e-05 | 3 | 172 | 2 | 25027557 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 30478938 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 20600019 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 15631944 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 19020519 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 23360525 | ||
| Pubmed | Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide. | 7.27e-05 | 3 | 172 | 2 | 17823376 | |
| Pubmed | Interleukin-10 inhibition of nitric oxide biosynthesis involves suppression of CAT-2 transcription. | 7.27e-05 | 3 | 172 | 2 | 11829538 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 10516026 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 36672824 | ||
| Pubmed | Probing muscle ankyrin-repeat protein (MARP) structure and function. | 7.27e-05 | 3 | 172 | 2 | 25125175 | |
| Pubmed | α-Synuclein modulates neurite outgrowth by interacting with SPTBN1. | 7.27e-05 | 3 | 172 | 2 | 22771809 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 33372035 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 28507505 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 15928712 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 7.27e-05 | 3 | 172 | 2 | 33410423 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 18713734 | ||
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 22898814 | ||
| Pubmed | LIN7 regulates the filopodium- and neurite-promoting activity of IRSp53. | 7.27e-05 | 3 | 172 | 2 | 22767515 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 21173574 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 7.27e-05 | 3 | 172 | 2 | 34289389 | |
| Pubmed | 7.68e-05 | 17 | 172 | 3 | 20808911 | ||
| Pubmed | 8.65e-05 | 209 | 172 | 7 | 36779422 | ||
| Pubmed | 9.18e-05 | 18 | 172 | 3 | 18664271 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 9.70e-05 | 92 | 172 | 5 | 15840729 | |
| Pubmed | BICD2 TOR1AIP2 ACOT8 EPPK1 RTN3 CCNT1 AKAP9 SF3A3 LMAN2 HERC2 | 1.00e-04 | 457 | 172 | 10 | 22190034 | |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 1.07e-04 | 94 | 172 | 5 | 37468549 | |
| Pubmed | 1.09e-04 | 19 | 172 | 3 | 15024025 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.12e-04 | 218 | 172 | 7 | 33378226 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ARHGAP32 LIN7C ANK3 SLC26A2 DOCK9 SPTBN1 PSD3 SLC39A10 PTPN3 | 1.17e-04 | 377 | 172 | 9 | 38117590 |
| Interaction | TNIK interactions | BICD2 TANC2 ARHGAP32 ANK2 ANK3 FOXP2 SPTBN1 AKAP9 SRGAP3 INTS13 PAFAH1B1 BRD7 MACF1 HERC2 AGRN | 7.48e-07 | 381 | 168 | 15 | int:TNIK |
| Interaction | GSK3B interactions | BICD2 MASP1 DNAJC13 RAPGEF6 APBA1 CLASP2 CHD3 RBM28 BCAR1 ANKRD6 GMPS IBTK SNCAIP MTUS1 MTHFD1 MACF1 LTA4H LMAN2 HERC2 HECTD1 VCPIP1 | 1.17e-05 | 868 | 168 | 21 | int:GSK3B |
| Cytoband | 3q22.1 | 1.95e-05 | 42 | 173 | 4 | 3q22.1 | |
| GeneFamily | Ankyrin repeat domain containing | TANC2 ANKS6 ANK2 ANK3 ANKRD23 ANKS4B ANKRD6 IBTK SNCAIP ANKRD2 KANK3 OSBPL1A HECTD1 ANKS3 ARAP1 | 7.87e-11 | 242 | 121 | 15 | 403 |
| GeneFamily | Mannosidases alpha class 2 | 4.38e-04 | 5 | 121 | 2 | 1194 | |
| GeneFamily | PDZ domain containing | 5.55e-04 | 152 | 121 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.13e-04 | 7 | 121 | 2 | 1113 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 9.41e-04 | 29 | 121 | 3 | 396 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.21e-03 | 8 | 121 | 2 | 939 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.55e-03 | 9 | 121 | 2 | 1223 | |
| GeneFamily | PHD finger proteins|NuRD complex | 2.81e-03 | 12 | 121 | 2 | 1305 | |
| GeneFamily | Sterile alpha motif domain containing | 2.89e-03 | 88 | 121 | 4 | 760 | |
| GeneFamily | EF-hand domain containing | 3.57e-03 | 219 | 121 | 6 | 863 | |
| GeneFamily | OTU domain containing | 5.66e-03 | 17 | 121 | 2 | 669 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | TANC2 NRAP TGIF2LY ANK2 PSD3 NUBP1 COL6A5 CLASP2 RDH13 HRNR BCAR1 WDFY4 F13A1 CCDC7 DDIAS PTPN3 CRYZ GUCY1A1 PDZD8 TGIF2LX LIMCH1 CAMTA1 | 3.00e-08 | 873 | 164 | 22 | M16009 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | MAN2A2 ANK2 ANK3 FOXP2 SOBP NAP1L5 APBA1 MYRIP CLASP2 CHD3 CHGA C2CD4C TBC1D9 PTPN3 AKAP9 CHD5 CDH3 | 1.69e-07 | 584 | 164 | 17 | M39068 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AKAP6 TANC2 PTBP3 RAPGEF6 ENOX1 ANK2 ANK3 SOBP NAP1L5 APBA1 CHD3 CHGA PCGF3 CLIP1 TBC1D9 AKAP9 MTUS1 GUCY1A1 SRGAP3 CHD5 PCDH11X BOD1L1 CAMTA1 | 4.40e-07 | 1106 | 164 | 23 | M39071 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | BICD2 DNAJC13 AGO2 MAN2A2 ANK2 DOCK9 SPTBN1 CHD3 RBM28 PCGF3 CLIP1 JMJD1C AKAP9 ZBTB10 MACF1 ADAM17 HERC2 | 1.01e-05 | 790 | 164 | 17 | M12490 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 1.13e-05 | 168 | 164 | 8 | M6874 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | BICD2 TOR1AIP2 SLC12A6 FOXP2 PSD3 SIRPB1 ITPRID2 CLIP1 YOD1 SNCAIP MTUS1 GUCY1A1 KANK3 UBR3 MACF1 MYOM2 MME PROS1 | 1.23e-05 | 888 | 164 | 18 | MM1018 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | TANC2 TCEA2 SDK2 ANK2 ANK3 SOBP SPTBN1 PENK WDR59 GUCY1A1 PCDH11X LIMCH1 TRIM44 | 1.31e-05 | 488 | 164 | 13 | M39104 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | PTBP3 RAPGEF6 AGO2 ENOX1 GPR65 SPTBN1 UST JMJD1C IBTK THADA MACF1 LTA4H HECTD1 | 1.63e-05 | 498 | 164 | 13 | M1741 |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN | 1.83e-05 | 130 | 164 | 7 | M6087 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | PTBP3 RAPGEF6 AGO2 ENOX1 GPR65 SPTBN1 UST JMJD1C IBTK THADA MACF1 LTA4H HECTD1 | 1.96e-05 | 507 | 164 | 13 | MM1030 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | BICD2 TOR1AIP2 SLC12A6 FOXP2 PSD3 ITPRID2 CLIP1 YOD1 SNCAIP MTUS1 GUCY1A1 KANK3 UBR3 MACF1 MYOM2 MME PROS1 | 2.73e-05 | 854 | 164 | 17 | M1533 |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 2.82e-05 | 139 | 164 | 7 | M6754 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 3.42e-05 | 196 | 164 | 8 | M5381 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_DN | 3.55e-05 | 197 | 164 | 8 | M3173 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN | 6.64e-05 | 159 | 164 | 7 | M8125 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MASP1 ANK3 FOXP2 CLASP2 BCAR1 GMPS CCNT1 GUCY1A1 EBP OSBPL1A HECTD1 AGRN | 8.22e-05 | 503 | 164 | 12 | M2226 |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN | 9.74e-05 | 169 | 164 | 7 | M6504 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | SLC12A6 NAB1 NUBP1 ITPRID2 WDFY4 TBC1D9 LIN7A MACF1 LTA4H ADAM17 MME | 9.82e-05 | 435 | 164 | 11 | M41115 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 AGO2 DOCK9 PSD3 GBE1 CLASP2 CLIP1 UST GMPS PIK3R4 IBTK AKAP9 PAFAH1B1 MACF1 ADAM17 TRIM44 | 9.93e-05 | 856 | 164 | 16 | M4500 |
| Coexpression | GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.01e-04 | 118 | 164 | 6 | M9155 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | TANC2 ENOX1 ANK2 FOXP2 GBE1 CLASP2 ANKRD6 C2CD4C TBC1D9 PTPN3 GUCY1A1 SRGAP3 OSBPL1A | 1.16e-04 | 604 | 164 | 13 | M45760 |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 1.17e-04 | 174 | 164 | 7 | M6296 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP | 1.54e-04 | 182 | 164 | 7 | M4255 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MASP1 ANK3 FOXP2 CLASP2 BCAR1 GMPS CCNT1 GUCY1A1 EBP OSBPL1A HECTD1 AGRN | 1.62e-04 | 541 | 164 | 12 | MM1061 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | TANC2 PTBP3 LIN7C FOXP2 CLASP2 IBTK AKAP9 PAFAH1B1 PCDH11X MME HERC2 AGRN TRIM44 | 1.28e-06 | 330 | 159 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AKAP6 TANC2 PTBP3 LIN7C ANK2 FOXP2 NAP1L5 MYRIP CLASP2 SLC39A10 ANKRD6 TBC1D9 IBTK AKAP9 PAFAH1B1 PCDH11X MME HERC2 AGRN TRIM44 | 3.33e-06 | 818 | 159 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | LIMA1 MAN2A2 FOXP2 AMACR CLIP1 F13A1 SNCAIP BRD7 UBR3 MACF1 BOD1L1 CEP295 MAP3K19 | 2.34e-05 | 432 | 159 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ARHGAP32 LIMA1 ANK3 SPTBN1 SLC7A2 PTPN3 AKAP9 PTPRZ1 SRGAP3 HECTD1 | 4.64e-09 | 200 | 167 | 10 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ARHGAP32 LIMA1 ANK3 SLC7A2 PTPN3 AKAP9 MTUS1 PTPRZ1 SRGAP3 HECTD1 | 4.64e-09 | 200 | 167 | 10 | ecbe89ff95d046155b984c8c150e0b9e7278f839 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.38e-08 | 184 | 167 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.25e-08 | 189 | 167 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.32e-08 | 194 | 167 | 9 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.32e-08 | 194 | 167 | 9 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-08 | 196 | 167 | 9 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-08 | 196 | 167 | 9 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.07e-08 | 197 | 167 | 9 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.07e-08 | 197 | 167 | 9 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.34e-08 | 198 | 167 | 9 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 6.34e-08 | 198 | 167 | 9 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.62e-08 | 199 | 167 | 9 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.62e-08 | 199 | 167 | 9 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-07 | 179 | 167 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.50e-07 | 182 | 167 | 8 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.09e-07 | 185 | 167 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.99e-07 | 189 | 167 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.23e-07 | 190 | 167 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-07 | 190 | 167 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.23e-07 | 190 | 167 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.01e-07 | 193 | 167 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-07 | 194 | 167 | 8 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 195 | 167 | 8 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-07 | 197 | 167 | 8 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.18e-07 | 197 | 167 | 8 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.18e-07 | 197 | 167 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 198 | 167 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 198 | 167 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 8.83e-07 | 199 | 167 | 8 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 8.83e-07 | 199 | 167 | 8 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-07 | 199 | 167 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.83e-07 | 199 | 167 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.83e-07 | 199 | 167 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.17e-07 | 200 | 167 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.17e-07 | 200 | 167 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 9.17e-07 | 200 | 167 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 9.17e-07 | 200 | 167 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Severe-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.12e-06 | 142 | 167 | 7 | 9c7d5783302974b883bd887f997d094eb5925ec2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-06 | 145 | 167 | 7 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 160 | 167 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 160 | 167 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-06 | 161 | 167 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 163 | 167 | 7 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-06 | 163 | 167 | 7 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.70e-06 | 170 | 167 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.70e-06 | 170 | 167 | 7 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-06 | 171 | 167 | 7 | 9d5cabd71a901a00eb16c4d151189296f1b3bf6f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 176 | 167 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.80e-06 | 182 | 167 | 7 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.23e-06 | 184 | 167 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 6.45e-06 | 185 | 167 | 7 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-06 | 185 | 167 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-06 | 185 | 167 | 7 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 186 | 167 | 7 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 186 | 167 | 7 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.68e-06 | 186 | 167 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.92e-06 | 187 | 167 | 7 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 6.92e-06 | 187 | 167 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-06 | 188 | 167 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 7.17e-06 | 188 | 167 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-06 | 188 | 167 | 7 | d534ed9870405a3c1075962308f72b460aed17bf | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.42e-06 | 189 | 167 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.42e-06 | 189 | 167 | 7 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.42e-06 | 189 | 167 | 7 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 7.42e-06 | 189 | 167 | 7 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.42e-06 | 189 | 167 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.42e-06 | 189 | 167 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 7.68e-06 | 190 | 167 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.95e-06 | 191 | 167 | 7 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.95e-06 | 191 | 167 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 7.95e-06 | 191 | 167 | 7 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 8.22e-06 | 192 | 167 | 7 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-06 | 192 | 167 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-06 | 192 | 167 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.22e-06 | 192 | 167 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 193 | 167 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 193 | 167 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.50e-06 | 193 | 167 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 193 | 167 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.50e-06 | 193 | 167 | 7 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.50e-06 | 193 | 167 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 193 | 167 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-06 | 194 | 167 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 9.09e-06 | 195 | 167 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 195 | 167 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-06 | 195 | 167 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-06 | 195 | 167 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.09e-06 | 195 | 167 | 7 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 9.09e-06 | 195 | 167 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 196 | 167 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC1|ICU-SEP / Disease, condition lineage and cell class | 9.72e-06 | 197 | 167 | 7 | e3174e90ea6136f1aa3a4a185b86458e35d51fd4 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.72e-06 | 197 | 167 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 9.72e-06 | 197 | 167 | 7 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-05 | 198 | 167 | 7 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-05 | 198 | 167 | 7 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-05 | 198 | 167 | 7 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| Drug | dexamethasone; Up 200; 1uM; ssMCF7; HG-U133A | BICD2 GCFC2 SOBP SLC26A2 DOCK9 EML2 CHD3 CDC37L1 THADA PAFAH1B1 | 1.91e-06 | 198 | 165 | 10 | 374_UP |
| Drug | alanine-p-nitroanilide | 2.52e-06 | 14 | 165 | 4 | CID000150936 | |
| Disease | Apraxia of Phonation | 8.73e-05 | 3 | 160 | 2 | C0264611 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.05e-04 | 197 | 160 | 7 | EFO_0005680 | |
| Disease | cerebral amyloid angiopathy (is_marker_for) | 1.74e-04 | 4 | 160 | 2 | DOID:9246 (is_marker_for) | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.74e-04 | 4 | 160 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 2.91e-04 | 24 | 160 | 3 | EFO_0006897 | |
| Disease | Schizophrenia | ARHGAP32 RAPGEF6 ANK3 FOXP2 AMACR PSD3 SIRPB1 TDO2 CHGA MTHFD1 PTPRZ1 SRGAP3 PAFAH1B1 ERVK-8 | 3.40e-04 | 883 | 160 | 14 | C0036341 |
| Disease | extraversion | 4.32e-04 | 6 | 160 | 2 | EFO_0004317 | |
| Disease | Lissencephaly | 4.32e-04 | 6 | 160 | 2 | C0266463 | |
| Disease | Nonorganic psychosis | 5.47e-04 | 69 | 160 | 4 | C0349204 | |
| Disease | testosterone measurement | LIMA1 ANK2 ANK3 NAB1 TRPM2 GLYCTK PSD3 JMJD1C CDC37L1 THADA HMCN1 MTHFD1 ZBTB10 MACF1 LMAN2 MME ARAP1 | 5.84e-04 | 1275 | 160 | 17 | EFO_0004908 |
| Disease | free cholesterol to total lipids in large LDL percentage | 7.13e-04 | 74 | 160 | 4 | EFO_0022280 | |
| Disease | Malignant neoplasm of breast | AKAP6 ANK2 BCAR1 CLIP1 PIK3R4 FOXP4 AKAP9 SRGAP3 CHD5 MACF1 BOD1L1 MME HERC2 LONRF3 NOS2 | 7.78e-04 | 1074 | 160 | 15 | C0006142 |
| Disease | Thrombophilia due to thrombin defect | 8.01e-04 | 8 | 160 | 2 | cv:C3160733 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 8.01e-04 | 8 | 160 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | breast cancer anti-estrogen resistance protein 3 measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0008040 | |
| Disease | autosomal dominant compelling helio-ophthalmic outburst syndrome | 8.28e-04 | 77 | 160 | 4 | EFO_0007887 | |
| Disease | sexual dimorphism measurement | LIMA1 RAPGEF6 EPPK1 LIN7C CLIP1 JMJD1C OMG SPTBN5 FER1L4 ZNF335 KANK3 SF3A3 MACF1 DOT1L ANKS3 | 1.04e-03 | 1106 | 160 | 15 | EFO_0021796 |
| Disease | waist-hip ratio | BICD2 TCEA2 ITGA11 ANK3 NAB1 ZNF407 ANKRD6 JMJD1C MEP1A SLC7A2 THADA SRGAP3 PDZD8 ADAM17 CPNE4 DOT1L | 1.06e-03 | 1226 | 160 | 16 | EFO_0004343 |
| Disease | chronotype measurement | TANC2 GCFC2 ANK2 ANK3 FOXP2 NAB1 GBE1 CLIP1 FOXP4 PAFAH1B1 PCDH15 PDZD8 CAMTA1 | 1.08e-03 | 882 | 160 | 13 | EFO_0008328 |
| Disease | Situs Inversus | 1.56e-03 | 11 | 160 | 2 | C0037221 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.86e-03 | 12 | 160 | 2 | C3160718 | |
| Disease | beta wave measurement | 1.86e-03 | 12 | 160 | 2 | EFO_0006871 | |
| Disease | Psychotic Disorders | 2.26e-03 | 101 | 160 | 4 | C0033975 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.54e-03 | 50 | 160 | 3 | EFO_0022303 | |
| Disease | Opioid use measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0009937 | |
| Disease | glycerate measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0021029 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.15e-03 | 447 | 160 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | reaction time measurement | AKAP6 BICD2 GCFC2 FOXP2 GBE1 UST PTPRZ1 SRGAP3 PAFAH1B1 CAMTA1 | 3.26e-03 | 658 | 160 | 10 | EFO_0008393 |
| Disease | Cardiovascular Abnormalities | 3.34e-03 | 16 | 160 | 2 | C0243050 | |
| Disease | Romano-Ward Syndrome | 3.34e-03 | 16 | 160 | 2 | C0035828 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.69e-03 | 57 | 160 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | sleep duration | 3.72e-03 | 362 | 160 | 7 | EFO_0005271 | |
| Disease | mean platelet volume | SLC12A6 ARHGAP32 ATP8B4 SPTBN1 NAB1 PSD3 RDH13 SIRPB1 JMJD1C PAFAH1B1 ZBTB10 CAMTA1 ARAP1 | 3.82e-03 | 1020 | 160 | 13 | EFO_0004584 |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 4.07e-03 | 59 | 160 | 3 | EFO_0022260 | |
| Disease | cleft lip | 4.65e-03 | 284 | 160 | 6 | EFO_0003959 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 4.68e-03 | 62 | 160 | 3 | EFO_0022306 | |
| Disease | skin sensitivity to sun | 4.70e-03 | 19 | 160 | 2 | EFO_0004795 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.70e-03 | 19 | 160 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | puberty onset measurement | 4.85e-03 | 125 | 160 | 4 | EFO_0005677 | |
| Disease | Ulcerative Colitis | 4.90e-03 | 63 | 160 | 3 | C0009324 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 4.90e-03 | 63 | 160 | 3 | EFO_0022292 | |
| Disease | Colorectal Carcinoma | 5.11e-03 | 702 | 160 | 10 | C0009402 | |
| Disease | coagulation factor measurement | 5.21e-03 | 20 | 160 | 2 | EFO_0004634 | |
| Disease | polymyositis | 5.21e-03 | 20 | 160 | 2 | EFO_0003063 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAAKSVSEDVHVHSL | 66 | O14734 | |
| LHAAASAGEHEKVVQ | 636 | Q8WVB6 | |
| DPHAAHGSEVDRLKA | 326 | Q7L0X2 | |
| GLLTDHHESLDNDVA | 36 | Q9Y2D5 | |
| KHDVSAHHDLNIDQS | 46 | Q99996 | |
| SEVQHNDVSEGKHEH | 301 | Q9Y6Y1 | |
| KEGDTALHEAVRHGS | 241 | Q86SG2 | |
| HTNHKKVAADGESRE | 86 | Q8TD16 | |
| IQSKSHGETDKEHLA | 1111 | Q96M83 | |
| AESHQHLSKESLAGN | 1836 | Q8TDI0 | |
| SSGHDSSLFEDKNDH | 41 | Q9NPI1 | |
| VGNAAHTSDRALHAK | 526 | P56945 | |
| HDHNKERGSFITSEE | 306 | Q9UHK6 | |
| SEEAEATKAHHALEQ | 1336 | Q12774 | |
| DSGALHSEKALQSNH | 1901 | O00468 | |
| HSLAHALESDVKNDL | 761 | Q8TF62 | |
| VHAAADKHNSVEDSV | 486 | O60563 | |
| ALAKVAQHHLEGAQS | 3051 | Q96M86 | |
| AASELHSRAEHTKEN | 796 | Q8TEK3 | |
| HAAAEEKSAIQANDH | 626 | P52569 | |
| RKESLFHSEHGALAQ | 161 | Q8TF44 | |
| HLVDKEHDSAEGSHT | 816 | Q9UKV8 | |
| HEKNQAGDTALHVAA | 201 | Q9Y2G4 | |
| AGDTALHVAAALNHK | 206 | Q9Y2G4 | |
| THSAHFKVDLDVAGL | 521 | Q16853 | |
| EANHLLHESDTDKDG | 281 | Q96D15 | |
| VSAIGEEKSHESKHQ | 201 | Q9NW13 | |
| KQHLDSHRNGETKAD | 116 | Q3KNV8 | |
| ADDLARHNDHALSTK | 336 | Q9Y5P8 | |
| EKVAEAHENIIHGSG | 306 | Q08257 | |
| LKGHTDSVQDISFDH | 146 | P43034 | |
| LHEQHSGLKQSEAES | 191 | P26045 | |
| HKHGDLCEVSLTDSV | 366 | Q08AF8 | |
| ETIHEHNKLAANSDH | 181 | Q9NVM9 | |
| AEAREHAKETGHTNF | 331 | Q5VVQ6 | |
| GDKSLSNVIAHEISH | 286 | P09960 | |
| FSAHLAHGLAEDENT | 71 | P53384 | |
| TLLGQDHILHSDEAS | 41 | A0A2R8YFM6 | |
| HHQDGSDNEEEVSKR | 171 | P01210 | |
| ADILTKHGADQDAHT | 711 | Q01484 | |
| AFAHDIDQKLSHLGA | 636 | P35228 | |
| AHKEEDHHAVTTDNV | 566 | Q7Z353 | |
| LSVNGVSVEGEHHEK | 156 | O14910 | |
| LSVNGVSVEGEHHEK | 141 | Q9NUP9 | |
| ITDGNSEHLKREHSL | 46 | Q12907 | |
| HAASGAKADQEEQIH | 111 | Q9UHB6 | |
| LVHAKNAQALASDHD | 1366 | Q86VF7 | |
| NAAHETSKLEIEASH | 1041 | Q9ULD2 | |
| GKHLTLHELTVNEAA | 266 | Q13506 | |
| ASRNIVKIAAHSDGH | 491 | O95714 | |
| HHKDIALSLVAASDG | 336 | Q9P2D0 | |
| KDHDIGTTNLHIEVS | 2326 | Q15652 | |
| DIALAADHHSKHEAQ | 1081 | Q2LD37 | |
| HDKQETDVHFNSLTG | 1531 | A9Z1Z3 | |
| LKEGESDHHVVTNVE | 796 | Q8NEN9 | |
| TQADVSSRKHHVDND | 436 | Q8IXT1 | |
| VHEDLNGSLDHIDSN | 641 | O15409 | |
| VSGSKLRDDTHQHQE | 96 | Q86YZ3 | |
| GTDDKNSVNHVIHID | 206 | P08473 | |
| KAQELHALTHVNAAG | 591 | P63132 | |
| VISHFSGAALEKEQH | 506 | O94854 | |
| KKDGTHVVENVDATH | 446 | P00488 | |
| KHLNTEHALDDRSTA | 326 | Q8IVH2 | |
| QLSAEEDGSVHHESI | 251 | Q8N8V4 | |
| HHLEIELAAGSDSNE | 921 | Q9UKX5 | |
| KHVADLHASSGFTEE | 1706 | P23471 | |
| LHATDADIGENAKIH | 271 | Q9BZA7 | |
| ATEHHELEQSLVKGS | 451 | Q9BXW6 | |
| IDNKGNHLLVHEESS | 241 | A7KAX9 | |
| LVSENHDNAHVEGSE | 1401 | Q2PPJ7 | |
| LSLGAEANHLHESDA | 116 | P28290 | |
| KAQELHALTHVNAAG | 591 | P63135 | |
| KAQELHALTHVNAAG | 591 | Q9BXR3 | |
| NLSSLAHVAGHIDFD | 171 | Q8NBN7 | |
| KSDDHVNIAANGHTL | 2716 | Q96RW7 | |
| KAQELHALTHVNAAG | 591 | Q9QC07 | |
| SSNTIEAHKSAHVDG | 1486 | Q96QU1 | |
| EAHKSAHVDGSLKSN | 1491 | Q96QU1 | |
| AEEHVAQGDATLEHS | 1261 | Q8NFC6 | |
| LVLEDEKHHGAQSAA | 71 | Q9GZV1 | |
| LSSLLKHEDHQVSDG | 191 | Q9ULT8 | |
| DVVHSHASKNSADGL | 286 | Q04446 | |
| SIHDQDHKVLVLDSG | 61 | Q9NZH6 | |
| HKHGDLCEVSLTDSV | 366 | Q0D2H9 | |
| ASGKAELIKTHHNDT | 381 | P49915 | |
| HSDADVLHQSLLEAN | 1381 | Q9BZ29 | |
| EGLDIATFLAHNDSH | 476 | Q8IVS8 | |
| KLEHGDSHQTESLLD | 201 | Q8WXQ3 | |
| DKIHHSSESKDDQGL | 101 | P16383 | |
| VKSLGEHIASHIQDE | 151 | Q7Z4J2 | |
| AECLAESHQHLSKES | 1836 | Q12873 | |
| ALKHANALFTEEHGS | 896 | A8TX70 | |
| HDISSNHNGLKEADF | 96 | Q96A23 | |
| HNHTDTAEGDVIAAA | 86 | Q02410 | |
| NALHLASKEGHVEVV | 76 | Q12955 | |
| VERHADVDKQDSVHG | 346 | Q68DC2 | |
| ITHAAKVESEQHGDR | 1731 | O75165 | |
| ALSDFTHLHEKQGSE | 116 | A8MTA8 | |
| FQHHDAITGTAKEAV | 566 | P49641 | |
| LDHINSHAAELGVSV | 306 | Q9Y2E5 | |
| SDENEQHLGVKHTTL | 526 | P48740 | |
| KDQLLVAHHSEGATN | 526 | Q6UXX5 | |
| HGVKVDARDHSGATA | 191 | Q6ZW76 | |
| DEVAALLHAHLSSGQ | 776 | Q6NY19 | |
| DTETHDLVAIHTDGN | 446 | O95834 | |
| KAVLHDSCNLGLDAH | 1211 | Q8NDH2 | |
| GHRKFLAAAHNSADE | 541 | I6L899 | |
| DAVKHLTHAQSTLDA | 206 | Q15125 | |
| HLASEDTSAKQSGEH | 1806 | Q9C0D2 | |
| SQVADHLDHIKEVAG | 281 | P16444 | |
| SITGEHSQLLDDGHK | 96 | Q9UHW9 | |
| EEGEKHQSVSHGEAA | 116 | Q58EX2 | |
| EEKIIDHSHSDGLHT | 601 | Q9ULF5 | |
| GTKELVETNGHSHED | 521 | Q8TC92 | |
| HSKTAHLDEEVNKGD | 196 | P11586 | |
| DVHLSLSDHGNKEQL | 616 | P22223 | |
| SKAVHSNLHDIENGD | 746 | Q56UN5 | |
| TSLKEHFGAREETHQ | 571 | P30622 | |
| LALHNSESLDQEHAK | 81 | Q7L3B6 | |
| HGLTAFHLLDVADNA | 321 | Q6UY18 | |
| VSKGVHEDHQLDTEA | 911 | Q9UPQ0 | |
| NRDHDTDSKHNKVGV | 316 | O14829 | |
| DAGVHALSNAAHLDV | 66 | Q8N0Z8 | |
| ESLHGKNVKHIDDSS | 636 | O95197 | |
| AHQGHQLSTLDEAFE | 206 | Q96DX7 | |
| TGKDAHATHLQSTEA | 126 | Q8IUE1 | |
| KHGTNSDFQHELTDI | 1421 | Q6YHU6 | |
| EILHSACGLSKDHQE | 41 | Q8NFQ8 | |
| ALEKTEHASGIGDHS | 1306 | Q8TEU7 | |
| TGKDAHATHLQSTEA | 126 | Q8IUE0 | |
| ELQSETKGNKIHDEH | 56 | P48775 | |
| AEAAAGAKHDDAHAE | 161 | Q96NT1 | |
| SEAHRDELLAQHAAG | 4801 | P58107 | |
| HQDSAQAGEVDHTLL | 291 | Q16819 | |
| ASAVIHDQHKLSTEE | 221 | Q9Y6H5 | |
| SLVDNGAATDHADKN | 1151 | Q9HCD6 | |
| LDEAISKHNDIRAHS | 651 | P07225 | |
| HEAAAATLTIHLQDG | 346 | P23515 | |
| DLLEAQVSAHGAHVS | 576 | Q9NRC6 | |
| DTVNHLADELINSGH | 1756 | Q01082 | |
| SHCALKEAVEEEGHQ | 831 | Q13023 | |
| TKEADLVTTHELGHN | 396 | P78536 | |
| HLKEGEQHVDDVSSA | 1016 | Q96P48 | |
| AHQQKKHSGFEDELS | 91 | P10645 | |
| DIDVNAAAGAKAHHA | 371 | O75122 | |
| DQSHLHDSSQKGVID | 806 | Q99570 | |
| LEISAHQKEHGSDIT | 346 | O00241 | |
| HQKEHGSDITHEAAL | 351 | O00241 | |
| SEKHGFNLVTSDIHN | 126 | Q9Y2C2 | |
| HEKHDNEDTASASEG | 346 | Q96JG6 | |
| HSSLGDHKSLEAEAL | 946 | O43295 | |
| VAATLASHFGKLHEN | 341 | P50443 | |
| ALHAHVKAEREPSAA | 671 | A7XYQ1 | |
| ALLKASRSQDHFGHE | 436 | O94759 | |
| SVLSAGSHEEDKLHC | 1166 | Q6ZT07 | |
| KAQELHALTHVNAAG | 591 | P10266 | |
| KAQELHALTHVNAAG | 591 | P63133 | |
| QAHAHTDDDSKPEAD | 516 | O15014 | |
| SSGRHKESQDKNDHI | 2311 | Q6ZS81 | |
| KAQELHALTHVNAAG | 591 | Q9UQG0 | |
| DSVGNTKTFDVEHSH | 96 | Q5VZM2 | |
| AAAHSAHTVKQEDIA | 861 | Q96JH7 | |
| ILEHAVNFEDHSNSG | 251 | Q8IYL9 | |
| DLGENHHLRVSFSKS | 536 | O95758 | |
| HQQLHSGEKSHTCDE | 166 | Q14588 | |
| HQHTASHGEEEALKE | 356 | Q6PJI9 | |
| LSHQSVAKRFLEDHG | 521 | Q6ZT12 | |
| KETSSALTHAGAHLD | 231 | Q12874 | |
| LTAALQTDHDHVAIG | 146 | Q15560 | |
| HVSTEHKLHEANAQE | 311 | Q96DT7 | |
| HDAESVLKHLEACSS | 471 | Q9C0G0 | |
| HQQLHSGEKSHTCDE | 166 | Q9NZL3 | |
| HGSNAHTALVEEFAK | 306 | O75604 | |
| EDFLLSHVAVKHTGA | 661 | Q9H4Z2 | |
| ALSEEDLKNAVSVHH | 836 | Q9NYI0 | |
| LSESKESHQHGEVLT | 71 | C9JN71 | |
| GGLHKESDTHAVQIA | 536 | Q02108 | |
| AAHKHGDLCEVSLTD | 531 | A6NN73 | |
| ESHENALHDAEIACK | 291 | Q496Y0 | |
| GQASLSFSHLHKDDE | 336 | P54296 | |
| HSGTDETHLADLEDQ | 726 | Q8NFW9 |